5QO.F QLUCORE AB
- Market cap
- EUR 1.19M
- P/E
- -
- P/B
- 0.36x
- ROE
- -34.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is 5QO.F undervalued?
Graham numberThe Graham number of QLUCORE AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
QLUCORE AB fundamental analysis
No fundamental analysis for QLUCORE AB yet.
QLUCORE AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About QLUCORE AB
Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. The company offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a CE-marked IVDR software which offers RNA-seq based cancer diagnostics. Qlucore AB (publ)…
Full company profileQLUCORE AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
QLUCORE AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 14.1M | 12.7M | 14.4M | 10.2M | 6.74M | 6.82M |
| Gross Profit | 5.43M | 5.80M | 18.1M | 1.23M | -207K | -2.88M |
| Operating Income | -11.5M | -16.3M | -16.7M | -20.4M | -16.4M | -11.3M |
| EBITDA | - | -11.9M | -11.3M | -15.6M | -28.8M | -4.86M |
| Net Income | -11.7M | -15.9M | -15.7M | -20.5M | -36.5M | -11.4M |
| EPS | -1.47 | -2.01 | -1.98 | -2.59 | -0.85 | -0.27 |
| Balance Sheet | ||||||
| Total Assets | 122M | 109M | 90.0M | 70.0M | 42.0M | 42.7M |
| Total Liabilities | 11.3M | 14.6M | 10.9M | 11.5M | 5.71M | 9.28M |
| Shareholders' Equity | 111M | 94.7M | 79.1M | 58.5M | 36.3M | 33.5M |
| Cash & Short-term Investments | 98.0M | 69.7M | 28.6M | 5.26M | 2.97M | 6.06M |
| Cash Flow | ||||||
| Operating Cash Flow | -6.81M | -8.05M | -16.9M | -14.2M | -12.5M | 16.4M |
| Capital Expenditure | 8.95M | 19.0M | 22.5M | 8.22M | 3.67M | 3.48M |
| Free Cash Flow | -15.8M | -27.1M | -39.5M | -22.4M | -16.1M | 12.9M |
| Ratios | ||||||
| ROE | -10.5% | -16.8% | -19.8% | -35.1% | -100.6% | -34.2% |
| ROA | -9.6% | -14.6% | -17.4% | -29.4% | -86.9% | -26.8% |
| Net Profit Margin | -82.6% | -125.8% | -109.1% | -201.2% | -542.1% | -168.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
QLUCORE AB dividends
QLUCORE AB has not paid dividends in the last 5 fiscal years.
Who owns QLUCORE AB
- Insiders 69.57%
- Institutions 6.70%
- Public & others 23.73%
- Shares outstanding 42.9M
- Free float 13.2M
QLUCORE AB company profile
- Company name
- QLUCORE AB
- Ticker
- 5QO.F
- ISIN
- SE0016829824
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- Software
- Employees
- 12
- Fiscal year end
- April
- Address
- Ideon Science Park, Lund, Sweden, 223 70
- Phone
- 46 4 62 86 31 10
- Website
- qlucore.com
About QLUCORE AB
Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. The company offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a CE-marked IVDR software which offers RNA-seq based cancer diagnostics. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
QLUCORE AB management
4- Mr. Carl-Johan Ivarsson MScCo-Founder, Chair of Scientific Advisory Board & CEO
- Mr. Thoas Fioretos M.D., Ph.D.Co-Founder & Member of Scientific Advisory Board · born 1962
- Mr. Johan RadeCo-Founder
- Mr. Per NordqvistHead of Quality